Disruption is the New Normal
Four years ago this month, the Business Group launched its Health Innovations Forum (HIF) to identify new solutions entering the employer market.Read More
New Treatments Require New Approaches?
Dylan Landers-Nelsons's Perspective on Multiple Sclerosis (MS), Medical Marijuana, and What Employers Can Do About ThemRead More
Pregnancy Loss Is Tough. Supporting Employees Through It Doesn't Have To Be.
Miscarriages are common. According to the March of Dimes, between 10-15% of known pregnancies end in miscarriage.Read More
Industry Innovators Changing the DNA of Health Care
“Hospitals of the future won’t look the same,” claims Business Health Agenda 2019 keynote speaker Dr. Stephen Klasko, CEO of Jefferson Health and President of Thomas Jefferson University.Read More
The Impact of Technology on Health Care: What's in Store for Large Employers?
We’ve all heard about artificial intelligence and how it’s going to change the way we interact and perceive the world around us. The health care industry is no exceptionRead More
Measles Outbreaks: Preventable But On the Rise
Measles is on the rise globally across all regions. Read More
Breaking Down Brexit
Brexit, the United Kingdom’s impending withdrawal from the European Union, is top of mind for Business Group. Our team recently conducted an interview with representatives from the British embassy to learn more about the situation and potential implications and associated outcomes.Read More
The Future of Genetic Testing & Treatments: Approaching the Tipping Point
While precision medicine and genetic testing are not new to the health care landscape, the sheer number of tests and the cost of treatments available has skyrocketed recently – with 10 new genetic tests entering the U.S. market daily.Read More
Navigating Rising Health Care Costs in the New Year
Health care costs are rising, and the new year will undoubtedly bring new challenges and more transformations. How do employers stay ahead of changes and keep costs low for our employees?Read More
The Shifting Landscape of the Hepatitis C Drug Marketplace: Generics on the Horizon
The FDA approval and release of treatments for hepatitis C in late 2013 were a game changer in the treatment of this disease. But the price tags caught self-insured employers off guard. Read More